Cardio Diagnostics Holdings, Inc. CDIO
1.65 USD -0.02 (-1.20%)
Regular-session close
1.63 -0.02 -1.21%
After hours · Nov 19, 4:00 PM ET
1.61 Day range 1.74
0.97 52-week range 7.91
- YTD
- -39.11%
- 1 year
- -35.55%
5D -0.28 (-14.21%)
- Market cap
- 4.88M
- Revenue (ttm)
- 39.14K
- EPS (ttm)
- -2.52
- Shares out
- 40.44M
- Forward P/E
- -4.12
- YTD return
- -39.11%
- 1-year return
- -35.55%
- 50-day average
- 0.44336
- Volume
- 30.77K
- Avg volume
- 27.40K
- Open
- 1.74
- Previous close
- 1.67
- Day's range
- 1.61 – 1.74
- 52-week range
- 0.97 – 7.91
- Beta
- 4.68
- Price target
- 2.00 (+21.2%)
Key statistics
- 200-day average
- 0.598455
- Enterprise value
- 5.91M
- Price / sales
- 1064.26
- Price / book
- 7.15
- Revenue growth
- 356.20%
- Free cash flow
- -5.92M
- Total cash
- 1.31M
- Total debt
- 870.45K
- Return on equity
- -293.27%
- Short % of float
- 5.52%
Fundamental scorecard
7 of 25 checks passed on CDIO’s reported financials
7of 25 checks passed
- Value 2 of 5
- Growth 1 of 5
- Profitability 1 of 5
- Financial health 3 of 5
- Dividend 0 of 5
Statements to Sep 30, 2026.
Financials — quick view
CDIO Revenue — quarterly 3.59K
CDIO Net income — quarterly -1.73M
CDIO EPS — quarterly -0.59
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 13, 2024 | Sep 1, 2024 | -0.15 | -0.06 | +0.09 | +60.00% |
| Jul 1, 2024 | Mar 1, 2024 | -0.10 | — | — | — |
| Apr 1, 2024 | Dec 1, 2023 | -0.13 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 27, 2024 | Benchmark | reit | Speculative Buy | Speculative Buy |
| Jun 6, 2024 | Benchmark | main | Speculative Buy | Speculative Buy |
| Apr 19, 2024 | Benchmark | main | Speculative Buy | Speculative Buy |
| Jun 15, 2023 | Benchmark | reit | Speculative Buy | Speculative Buy |
| May 22, 2023 | Northland Capital Markets | init | — | Outperform |
| Apr 18, 2023 | Benchmark | reit | — | Speculative Buy |
About Cardio Diagnostics Holdings, Inc.
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is headquartered in Chicago, Illinois.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- cardiodiagnosticsinc.com
News
Cardio Diagnostics To Present Data Supporting Its Technology’s Ability To Detect Non-Obstructive Coronary Artery Disease On A December 10 Investor Call
Cardio Diagnostics to Unveil Non-Obstructive Coronary Artery Disease Data, FDA Breakthrough Device Designation Strategy, and India Launch Update on December 10 Investor Call
Cardio Diagnostics' Whitepaper Examines Clinical Blind Spot in Coronary Heart Disease Detection and Care
Your note
Sign in to keep a note on CDIO — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BURTON PAUL FREDERICK | Director | Conversion of Exercise of derivative security | Mar 27, 2024 | 8,803 |
| DOGAN MEESHANTHINI | Chief Technology Officer | Purchase | Sep 5, 2024 | 197,310 |
| DOGAN TIMUR | Chief Technology Officer | Purchase | Sep 5, 2024 | 197,310 |
| INTRATER JAMES | Director | Conversion of Exercise of derivative security | Mar 27, 2024 | 71,596 |
| LAU STANLEY K | Director | Conversion of Exercise of derivative security | Mar 27, 2024 | 100,325 |
| LEVY ODED | Director | Conversion of Exercise of derivative security | Mar 27, 2024 | 71,596 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 2.64% | 1,067,062 | 1.10M | Sep 29, 2024 |
| Vanguard Group Inc | 0.57% | 232,139 | 239.10K | Sep 29, 2024 |
| Geode Capital Management, LLC | 0.46% | 184,409 | 189.94K | Sep 29, 2024 |
| Northern Trust Corporation | 0.12% | 48,619 | 50.08K | Sep 29, 2024 |
| State Street Corporation | 0.11% | 43,500 | 44.80K | Sep 29, 2024 |
| PNC Financial Services Group, Inc. | 0.10% | 40,500 | 41.71K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.57% | 232,139 | 239.10K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.29% | 116,769 | 120.27K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.07% | 27,496 | 28.32K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.05% | 20,997 | 21.63K | Oct 30, 2024 |
| Fidelity NASDAQ Composite Index Fund | 0.03% | 11,944 | 12.30K | Oct 30, 2024 |
